https://www.selleckchem.com/pr....oducts/Methazolaston
port the use of vedolizumab or ustekinumab as monotherapy for the treatment of IBD. In this systematic review, our objective was to assess inflammatory bowel disease (IBD) patient preferences and perspectives relating to their disease diagnosis, treatment, knowledge needs and telemedicine. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases and conference proceedings were searched between January 1, 1980, and May 1, 2020. The methodological
Like
Comment
Share
